表紙
市場調查報告書

藥物研發及再生醫療的生物銀行的全球市場

Biobanks Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 546540
出版日期 內容資訊 英文 116 Pages
商品交期: 2-3個工作天內
價格
藥物研發及再生醫療的生物銀行的全球市場 Biobanks Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年02月01日內容資訊: 英文 116 Pages
簡介

本報告提供藥物研發及再生醫療的生物銀行的全球市場調查,整體市場趨勢,各應用領域、地區的詳細趨勢,市場的推動要素及阻礙因素分析,競爭情形,主要企業簡介等,總括性彙整。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義
    • 簡介
  • 市場的推動要素
    • 政府及NGO的出資
    • 慢性疾病的盛行率上升
    • 再生醫療的進步
    • 藥物研發及藥品開發的發展
  • 市場阻礙因素
    • 法規上的課題
    • 保存設施的問題
    • 高成本

第4章 市場區隔:各應用領域

  • 藥物研發
  • 樣品收集、銷售信息
  • 再生醫療

第5章 市場區隔:各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 韓國
  • 其他地區
    • 巴西

第6章 競爭情形

  • 簡介
  • 收購、合併
  • 產業擴大
  • 新產品的投入

第7章 企業簡介

  • Core Dynamic Ltd
  • Atlanta Biologicals
  • Biolife Solutions
  • Bioniche Pharma USA Lc
  • Cell & Tissue Systems LLC
  • Essential Pharmaceuticals
  • Lifeline Scientific Inc
  • Genzyme Corporation
  • Preservation Solution
  • Sigma Aldrich Corporation
  • Teva Pharmaceutical Industries Ltd

第8章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 49822

Market Overview

The major factors for the growth of the global biobanks market include the innovations in regenerative medicine, the growing incidence of chronic diseases, advances in drug discovery and development, and R&D funding and investments by government and non-governmental organizations. These factors are expected to a boost the growth of the market over the forecast period.

Regenerative medicine through stem cell technology is one of the important treatments for diseases, such as Alzheimer's, diabetes, cancers, and rare genetic diseases. In order to benefit from the existing therapies, umbilical cord cells and other stem cells are preserved.

Stem cell practices are on the rise, globally, and are contributing to the development of new solutions for various diseases. Boston-based biotech start-up, Orig3n, is looking to build the largest and most diverse biobank, harnessing the power of induced pluripotent stem cell technology to accelerate regenerative medicine. Treatments for diseases, like muscular degeneration, using adult stem cells are now going into Phase 3 clinical trials in Japan. These successes are driving both the government and the private sector organizations into investing in more stem cell banks.

With the increase in awareness about stem cell therapies, there have been larger number of parents who are choosing umbilical cord banks for their children. There are a number of donor banks that are coming up as well. Biobanks not only aid in the therapies for genetic diseases, but also in medical research on rare genetic disorders. Increasing awareness about stem cell therapies and innovation in the field of regenerative medicine are driving the growth of the global biobank market.

Scope of the Report

As per the scope of the report, biobank is a biorepository, where various biomaterials (usually human specimens) are stored for research purpose. This study targets gaining a detailed overview of the market dynamics of the contemporary biobank market during the forecast period. It focuses on the need to develop strategic insights into the global and country-level markets, taking into consideration the demand for services and equipment in biobanks. The growth of this market is largely fueled by the increasing applications, increasing investments in R&D, technological advancements, and growing demand in the developing countries (China and India) of Asia-Pacific.

Key Market Trends

Cryogenic Storage Segment by Equipment is Expected to Account for the Largest Market Share During the Forecast Period

In biobanks, the cryogenic storage systems are basically used to store different life sciences materials at a very low temperature. The low temperature storage increases the longevity of the cells, while at the same time reducing the intensity of freezing damage. Various cryogenic storage devices are available that have been designed to allow storage of both liquid and vapor phase materials. The temperature in the cryogenic storage system is required to be maintained continuously. Currently, all demand is for automated cryogenic storage devices. This segment is further divided into refrigerators, ice machines, and freezers. With advanced storage and automated devices propelling the growth of the market, steady growth in the North American and European markets is expected.

North America Accounted for the Largest Share in the Global Market

North America is holds a major share in the global biobanks market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The United States has the largest expenditure for R&D and better healthcare infrastructure in the world. Different pharmaceutical/ biotech companies, academia, and research institutes are utilizing biobanks for the storage of DNA, RNA, tissue, serum, blood, plasma, cells, etc. According to the Hastings Center, a non-profit organization, 300 million biospecimens have been stored in the United States in various public and private biobanks. The market is in demand for the most advanced automated systems, and there is also a high adoption rate for new technology.

Competitive Landscape

The global biobanks market is moderately consolidated. Some of the segments are dominated by a few major players, while the other segments are distributed among multiple players. The market players are moreover, focusing on collaboration and partnership activities. For instance, BioLife Solutions and SAVSU collaborated to provide enhanced, cold-chain technologies for diabetes, lupus, pemphigus, and organ transplantation in October 2017.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Innovations in Regenerative Medicine
    • 4.2.2 Growing Incidences of Chronic Diseases
    • 4.2.3 Advances in Drug Discovery and Development
    • 4.2.4 R&D Funding and Investments by Government and Non-governmental Organizations
  • 4.3 Market Restraints
    • 4.3.1 Regulatory Issues
    • 4.3.2 Cost Constraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Equipment
    • 5.1.1 Cryogenic Storage Systems
      • 5.1.1.1 Refrigerators
      • 5.1.1.2 Ice Machines
      • 5.1.1.3 Freezers
    • 5.1.2 Alarm Monitoring Systems
    • 5.1.3 Other Equipment
  • 5.2 Media
    • 5.2.1 Optimized Media
    • 5.2.2 Non-optimized Media
  • 5.3 Services
    • 5.3.1 Human Tissue Biobanking
    • 5.3.2 Stem Cell Biobanking
    • 5.3.3 Cord Banking
    • 5.3.4 DNA/RNA Biobanking
    • 5.3.5 Other Services
  • 5.4 Application
    • 5.4.1 Regenerative Medicine
    • 5.4.2 Drug Discovery
    • 5.4.3 Disease Research
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Atlanta Biologicals Inc.
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 BioLifeSolutions Inc.
    • 6.1.4 Chart Industries Inc.
    • 6.1.5 Hamilton Company
    • 6.1.6 Qiagen NV
    • 6.1.7 Sigma-Aldrich Inc. (Merck KGaA)
    • 6.1.8 STEMCELL Technologies Inc.
    • 6.1.9 Thermo Fisher Scientific Inc.
    • 6.1.10 VWR International LLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS